IN2012DN03379A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03379A
IN2012DN03379A IN3379DEN2012A IN2012DN03379A IN 2012DN03379 A IN2012DN03379 A IN 2012DN03379A IN 3379DEN2012 A IN3379DEN2012 A IN 3379DEN2012A IN 2012DN03379 A IN2012DN03379 A IN 2012DN03379A
Authority
IN
India
Prior art keywords
present
spore
relates
coated
vaccine
Prior art date
Application number
Inventor
Simon Michael Cutting
Hong Anh Huynh
Original Assignee
New Royal Holloway & Bedford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Royal Holloway & Bedford filed Critical New Royal Holloway & Bedford
Publication of IN2012DN03379A publication Critical patent/IN2012DN03379A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a method of coating a spore with one or more therapeutic agents. The present invention also relates to a coated spore obtained by the method of the present invention and the use of the coated spore as a vaccine.
IN3379DEN2012 2009-09-21 2010-09-21 IN2012DN03379A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0916570.5A GB0916570D0 (en) 2009-09-21 2009-09-21 Method
PCT/GB2010/001771 WO2011033275A1 (en) 2009-09-21 2010-09-21 Bacterial spore having therapeutic agent adsorbed on its surface

Publications (1)

Publication Number Publication Date
IN2012DN03379A true IN2012DN03379A (en) 2015-10-23

Family

ID=41278080

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3379DEN2012 IN2012DN03379A (en) 2009-09-21 2010-09-21

Country Status (6)

Country Link
US (1) US8673311B2 (en)
EP (1) EP2480241A1 (en)
CN (1) CN102630163A (en)
GB (1) GB0916570D0 (en)
IN (1) IN2012DN03379A (en)
WO (1) WO2011033275A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932598B2 (en) * 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use
IL315468A (en) 2014-09-17 2024-11-01 Spogen Biotech Inc Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
MX2020003039A (en) 2017-09-20 2020-09-28 Spogen Biotech Inc Fusion proteins, recombinant bacteria, and exosporium fragments for plant health.
US20210252078A1 (en) * 2019-09-16 2021-08-19 Microbiome Labs, Llc Spore-based probiotic supplementation in chickens and effect on salmonella loads
CN110904002B (en) * 2019-11-25 2022-04-29 天津大学 Method for biologically removing tetracycline antibiotics
EP3842052B1 (en) 2019-12-23 2025-05-28 Senzyme GmbH Composition and methods for stabilising intestinal flora and improving hygiene
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
GB9810276D0 (en) 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
FR2798291B1 (en) * 1999-09-10 2005-01-14 Pasteur Institut IMMUNOGENIC ACELLULAR COMPOSITIONS AND VACCINE ACELLULAR COMPOSITIONS AGAINST BACILLUS ANTHRACIS
WO2002000232A2 (en) * 2000-06-26 2002-01-03 Maxygen, Inc. Methods and compositions for developing spore display systems for medicinal and industrial applications
GB0130789D0 (en) * 2001-12-21 2002-02-06 King S College London Application of spores
WO2010006326A2 (en) 2008-07-11 2010-01-14 Tufts University Methods and compositions for spore-based vaccines

Also Published As

Publication number Publication date
US8673311B2 (en) 2014-03-18
EP2480241A1 (en) 2012-08-01
WO2011033275A1 (en) 2011-03-24
CN102630163A (en) 2012-08-08
US20120237544A1 (en) 2012-09-20
GB0916570D0 (en) 2009-10-28

Similar Documents

Publication Publication Date Title
CY1123958T1 (en) METHOD OF PREPARATION OF CARBAMOYLPYRIDONE DERIVATIVES AND INTERMEDIATES
MX351464B (en) Methods for the treatment of allergic diseases.
TN2011000673A1 (en) Bace inhibitors
IN2012DN03883A (en)
MX367286B (en) Intranasal dexmedetomidine compositions and methods of use thereof.
MX340555B (en) Antibodies against il-18r1 and uses thereof.
CA2798214C (en) Vaccine against beta-herpesvirus infection and use thereof
IN2012DN03379A (en)
MX2012011829A (en) Anti-polyubiquitin antibodies and methods of use.
TN2012000610A1 (en) Heterocyclic compounds, their preparation and their therapeutic application
UA107204C2 (en) ANTI-FUNCTIONAL COMPOSITION CONTAINING THE PYTHIUM OLIGANDRUM Fungal Organism
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
MX2012010127A (en) Derivatives of aminoindanes, their preparation and their application in therapeutics.
MX367393B (en) ANTIFUNGAL COMPOSITIONS FOR THE TREATMENT OF SKIN and NAILS.
MX341340B (en) Flame treatment of a substrate.
UA112760C2 (en) THEOBROMIN IN COMBINATION WITH GUYPHENESINE FOR THE TREATMENT OF Cough
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea
MX2011011059A (en) Use of propineb as bird repellent.
MX349563B (en) Pharmaceutical formulation of nanonised fenofibrate.
WO2012065028A3 (en) Substituted tetracyclines
GR20120100608A (en) Pre-assembled exhibition construction
MX2013008559A (en) Leptin derivatives.
MX2013006526A (en) Dosages of arylsulfonamide derivatives.
UA94339C2 (en) use of Corvitine as frigoprotective agent
UA35660U (en) Use of antihomotoxic preparations as cytoprotectors